Home › NDC Lookup › RxCUI directory › RxCUI 1663612

Brompheniramine maleate 0.2 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Suspension — RxCUI 1663612

RxNorm drug concept · Semantic clinical drug
RxCUI 1663612 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1663612
Official nameBrompheniramine maleate 0.2 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbrompheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG per 10 ML Oral Suspension; brompheniramine maleate 2 MG / phenylephrine HCl 5 MG in 10 mL Oral Suspension; brompheniramine maleate 1 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Suspension
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)1,115 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
  • I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
  • You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
  • Can I use the nasal spray if I have high blood pressure or heart disease?
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Brompheniramine maleate 0.2 MG/ML / phenylephrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Brompheniramine maleate 0.2 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Suspension RxCUI 1663612

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Brompheniramine 1767
    • Phenylephrine 8163
    • Brompheniramine / phenylephrine 214324
    • Brompheniramine maleate 142427
    • Phenylephrine hydrochloride 8164
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brompheniramine / phenylephrine Oral Suspension 476826
    • Brompheniramine maleate / phenylephrine hydrochloride Oral Suspension 2648763
    • Brompheniramine / phenylephrine Oral Liquid Product 1156040
    • Brompheniramine / phenylephrine Oral Product 1156041
    • Brompheniramine maleate / phenylephrine hydrochloride Oral Liquid Product 2662491
    • Brompheniramine maleate / phenylephrine hydrochloride Oral Product 2663289
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Brompheniramine maleate 0.2 MG/ML 1053257
    • Phenylephrine hydrochloride 0.5 MG/ML 707273

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brompheniramine maleate 0.2 MG/ML SCDC · 1053257
  • Phenylephrine hydrochloride 0.5 MG/ML SCDC · 707273
  • Brompheniramine / phenylephrine Oral Suspension SCDF · 476826
  • Brompheniramine maleate / phenylephrine hydrochloride Oral Suspension SCDFP · 2648763
  • Brompheniramine / phenylephrine Oral Liquid Product SCDG · 1156040
  • Brompheniramine / phenylephrine Oral Product SCDG · 1156041
  • Brompheniramine maleate / phenylephrine hydrochloride Oral Liquid Product SCDGP · 2662491
  • Brompheniramine maleate / phenylephrine hydrochloride Oral Product SCDGP · 2663289

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1663612 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70000-0057-01 1 BOTTLE, PLASTIC in 1 BOX (70000-0057-1) / 118 mL in 1 BOT... Childrens Dibromm Cold and Allergy Cardinal Health (Leader) 70000 2020-04-30
Observed labelers: Cardinal Health (Leader) 70000 (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0248
Range $0.0248–$0.0248 · middle 50% $0.0248–$0.0248 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.